Thermo Fisher Scientific Inc.
Market Reports 📊 263 Reports
51. Epigenetics: Technologies and Global Markets
BCC Research Report: Dive into Personalized Medicine and Epigenomics Market the report includes epigenetic research tools and reagents, drugs, and IVDs market for epigenetic products is given for 2023
52. High-Throughput Screening: Technologies and Global Markets
BCC Research Report: Dive into high throughput screening market trends of high-throughput screening with data from 2023, estimates from 2024, projections of compound annual growth rates through 2029 (
53. Cell-Based Assays: Technologies and Global Markets
BCC Research Report: Dive into cell based assay market report also examines regional markets, focusing on North America, Europe, Asia-Pacific, and the Rest of the World (RoW).
54. Global Fluorescence Microscopy Market
BCC Research Report: Dive into fluorescence microscopy market estimates, data has been provided for 2021, 2022, and 2023 as the base year, 2024, and a forecast for 2029.
55. Liquid Biopsy Research Tools, Services and Diagnostics: Global Markets
BCC Research Report: Dive into Liquid Biopsy Research market estimations and trends, using 2023 as the base year and forecasting 2024 through 2029 with a CAGR projection.
56. Tissue Diagnostics: Technologies and Global Markets
BCC Research Report: Dive into tissue diagnostics market Current and historical market revenues can be estimated based on the technology type, test type, end user and by region.
57. In Vitro Diagnostics: Technologies and Global Markets
BCC Research Report: Dive into the in vitro diagnostics market analysis and estimates the CAGR for In vitro diagnostics technologies for the historical years 2021 and 2022.
58. High Content Screening/Imaging: Technologies and Global Markets
BCC Research Market Analyst says global market for high content screening and imaging is estimated to increase from $3.4 billion in 2024 to reach $5.1 billion by 2029 at a CAGR of 8.4%.
59. Biomarkers: Technologies and Global Markets
BCC Research Market Analyst says global market for biomarkers was valued at $63.7 billion in 2023. This market is expected to grow from $70.5 billion in 2024 to $130.2 billion by the end of 2029, at a
60. Bioprocess Optimization and Digital Bio-manufacturing: Global Markets
BCC Research Market Analyst says global market for bioprocess optimization and digital biomanufacturing is expected to grow from $24.3 billion in 2024 and is projected to reach $39.6 billion by the en
61. Laboratory Animal Models, 3D Cultures, and Organoids: Global Markets
BCC Research Market Analyst says global market for laboratory animal models, 3D cultures, and organoids is estimated to increase from $2.8 billion in 2024 to reach $5.0 billion by 2029.
62. Global DNA Sequencing: Research, Applied and Clinical Markets
BCC Research Market Analyst says global market for DNA sequencing is expected to grow from $14.8 billion in 2024 and is projected to reach $34.8 billion by the end of 2029, at a CAGR of 18.6%.
63. Microscopy: The Global Market
BCC Research Report: Dive into microscopy market estimates, data has been provided for 2021, 2022, and 2023 as the base year, 2024, and a forecast for 2029.
64. Softgel Capsules: Global Markets
BCC Research Market Analyst says global market for softgel capsules was valued at $7.4 billion in 2023. The market is expected to grow from $7.9 billion in 2024 to $11.5 billion by 2029 at a CAGR of 7
65. Environmental Sensing and Monitoring Technologies: Global Markets
BCC Research Market Analyst says global market for environmental sensing and monitoring technologies is estimated to increase from $31.3 billion in 2024 to reach $41.4 billion by 2029, at a CAGR of 5.
66. Global Market Opportunities and Competitive Landscape for CDMO
BCC Research Report: Dive into the contract development and manufacturing organization (CDMO) market analyzed to determine present and future market status, as well as forecasted growth from 2024 to 2
67. Induced Pluripotent Stem Cells: Global Markets
BCC Research Market Analyst says global market for induced pluripotent stem cells is expected to grow from $3.4 billion in 2023 to reach $5.2 billion by the end of 2028 at a CAGR of 9.1% from 2023 to
68. Single-use Technologies for Biopharmaceuticals: Global Markets
BCC Research Market Analyst says global market for single-use technologies for biopharmaceuticals is expected to grow from $6.5 billion in 2024 and is projected to reach $11.2 billion by the end of 20
69. Cell and Gene Therapy Tools, and Reagents: Global Markets
BCC Research Market Analyst says global market for Cell and Gene Therapy (CGT) Tools and Reagents is estimated to increase from $10.0 billion in 2024 to reach $16.7 billion by 2029, at a CAGR of 10.8%
70. CRISPR Technology: Global Markets
BCC Research Market Analyst says global market for CRISPR technology was valued at $3.4 billion in 2023 & is expected to grow from $3.8 billion in 2024 to $7.5 billion by the end of 2029.
71. Active Pharmaceutical Ingredients: Global Markets
BCC Research Market Analyst says global market for active pharmaceutical ingredients (APIs) is estimated to increase from $247.8 billion in 2023 to reach $347.9 billion by 2029 at a CAGR of 5.9%.
72. AI in Clinical and Molecular Diagnostics Market
BCC Research Market Analyst says global market for AI in clinical and molecular diagnostics is expected to grow from $2.6 billion in 2024 and is projected to reach $8.9 billion by the end of 2029.
73. Global Market for Contract Research Organization (CRO) Services
BCC Research Market Analyst says global market for contract research organization (CRO) services is expected to grow from $111.8 billion in 2024 and is projected to reach $166.0 billion by the end of
74. Medical Devices: Technologies and Global Markets
BCC Research Market Analyst says global market for medical devices reached $739.6 billion in 2023 & expected to grow from $810.4 billion in 2024 to $1.3 trillion by the end of 2029 at a CAGR of 9.8%.
75. Point-of-Care Diagnostics: Technologies and Global Markets
BCC Research Market Analyst says global market for point-of-care diagnostics was valued at $36.9 billion in 2023 & expected to grow from $40.6 billion in 2024 to $65.9 billion by the end of 2029 at a